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INTRODUCTION
Sarcoidosis is a systemic inflammatory disease that mainly affects 
Afro-descendant women 20-50 years old. The lungs are the most 
damaged organs (90%), followed by the eyes, skin, and liver. Ocular 
involvement occurs in 25%-80% of patients. Although anterior uveitis 
is the most common ocular manifestation, 28% of patients present 
with posterior uveitis, especially with venous involvement(1-4).
We present a case of a patient who had bilateral posterior uveitis 
with vasculitis due to sarcoidosis and who was IgM positive for toxo-
plasmosis, which made early diagnosis difficult.
CASE REPORT
A 27-year-old Afro-descendant woman complained of headache, 
asthenia, night fever, and bilateral painful upper eyelid edema for 2 
months. She also had bilateral ocular pain for 7 days. Her personal 
and familial past histories were unremarkable. Her best-corrected 
visual acuity (BCVA) was 20/20 in both eyes (OU). She presented with 
bilateral superior temporal eyelid edema, and anterior biomicroscopy 
revealed conjunctival injection and anterior chamber cells 3+(1), 
without other alterations in OU. The intraocular pressure was normal 
in OU, and fundoscopy showed vascular sheathing, mainly venous, 
with candle wax drippings sign in OU, and intraretinal hemorrhages 
in the left eye (OS) (Figure 1). Testing showed positive serology for 
to xoplasmosis detected by immunoenzymatic enzyme-linked im-
munosorbent assay (IgG >650 and IgM= 2.78), anergic PPD, but no 
other laboratory abnormalities. Fluorescein angiography showed 
perivascular hyperfluorescence by leakage (Figure 2).
Empirical treatment for ocular toxoplasmosis was started (oral 
sulfamethoxazole + trimethoprim 800/160 mg 1 pill twice a day and 
oral prednisone 1 mg/kg/day in regression 20 mg every 3 days) as 
well as topical treatment with prednisolone acetate 1% and tropica-
mide 1% drops in OU. After 3 weeks, the patient returned with im-
provement of systemic symptoms and bipalpebral edema but with 
worsening of retinal vasculitis in OU. Computed tomography (CT) 
of the orbit showed a bilateral increase in lacrimal glands (Figure 3), 
and chest X-ray radiography showed increased hilar lymph nodes 
and some pulmonary infiltrates, signs that were consistent with the 
diagnosis of pulmonary sarcoidosis stage II. The diagnosis of presu-
med ocular sarcoidosis was made. Antibiotics were discontinued 
and slowly regressive oral prednisone 1 mg kg−1day−1 and metho-
trexate were started. The patient showed clinical improvement, and 
after 1 year of follow-up, she presented without systemic or ocular 
complaints, with a BCVA of 20/20 in OU. Ocular examinations subse-
quently showed that she continued to exhibit sporadic small areas 
of vasculitis in OU, without other complications.
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ABSTRACT 
We report a case of ocular sarcoidosis with positive immunoglobulin (Ig) M and 
IgG serology for toxoplasmosis. The patient was a young female with red painful 
eyes, bilateral eyelid edema, and panuveitis with periphlebitis. In laboratory testing, 
she was IgM and IgG positive for toxoplasmosis and anergic in the tuberculin 
test. Topical treatment for anterior uveitis and oral antibiotics for toxoplasmosis 
were started, without improvement. Orbit tomography showed increased lacrimal 
glands bilaterally, and chest X-ray radiographic findings were consistent with 
pulmonary sarcoidosis, which supported the presumed ocular sarcoidosis diag-
nosis. The patient was treated with oral prednisone and methotrexate without 
antibiotics. She showed clinical and vision improvement without recurrences 
during the 1-year follow-up. Ocular sarcoidosis is an important differential diagnosis 
requiring careful anamnesis and ophthalmological examinations. Ancillary tests, 
such as X-ray radiography, tomography, and clinical and laboratory evaluations 
may help rule out other causes. Treatment mainly consists of corticosteroids and 
immunosuppression.
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RESUMO
Relatamos um caso de sarcoidose ocular com IgM e IgG positivos para toxoplasmose. 
Mulher jovem com quadro ocular bilateral de dor, vermelhidão, edema palpebral 
e panuveíte com periflebite. Os testes laboratoriais mostraram IgM e IgG positivos 
para toxoplasmose, teste tuberculínico anérgico. Realizou-se tratamento tópico da 
uveíte anterior e antibióticos orais para toxoplasmose, sem melhora. Tomografia de 
órbita mostrou aumento das glândulas lacrimais bilaterais e radiografia de tórax 
foi consistente com sarcoidose pulmonar, auxiliando no diagnóstico de sarcoidose 
ocular presumida. Iniciou-se prednisona e metotrexato orais, sem antibióticos, com 
melhora clínica e oftalmológica, sem recidivas em 1 ano de follow-up. Sarcoidose 
ocular é um importante diagnóstico diferencial que exige anamnese e exame 
oftalmológico cuidadosos. Exames complementares, como raio-X, tomografia 
computadorizada e avaliação clínica e laboratorial ajudam na avaliação e exclusão 
de outras causas. O tratamento consiste principalmente no uso de corticosteróide 
e imunossupressores.
Descritores: Sarcoidose; Toxoplasmose ocular; Uveíte posterior; Oftalmopatias
Ocular sarcOidOsis masked by pOsitive igm fOr tOxOplasmOsis
126 Arq Bras Oftalmol. 2017;80(2):125-7
Figure 3. Orbit CT showing bilateral diffuse lacrimal glands increase.
DISCUSSION
Sarcoidosis presents with non-caseating granulomas with epi-
thelioid cells in various tissues, but the etiology is unknown. The 
estimated incidence is approximately 15-21 per 100,000 habitants, 
and the prevalence is 1-40 per 100,000 habitants. The disease usually, 
affects people between 20 and 50 years of age, with a slight predomi-
nance in Afro-descendants and women. The course and manifesta-
tions of the disease vary depending on age, sex, race, and the affected 
organs. The disease can affect the entire body, mainly the lungs (90%) 
but also the eyes, skin, liver, spleen, central nervous system, cardio-
vascular system, kidneys, bones, and ligaments(2-5). 
Ocular sarcoidosis occurs in up to 50% of patients and affects the 
lacrimal glands, orbit, eyelids, conjunctiva, cornea, sclera, retina, cho-
roids, and optic nerve. Sarcoidosis is the cause of 2%-15% of all uveitis 
and is characterized by bilateral involvement (80%-90%) and a sym-
metrical clinical course. Anterior uveitis is the most common presen-
Figure 1. Retinography showing areas of venous vascular sheathing and candle wax drippings sign in both eyes. OD in the right and OS 
in the left.
Figure 2. Fluorescein angiography showing hyperfluorescence areas through leakage and capillaritis in both eyes. OD in the right and 
OS in the left.
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tation (41%-75%), with classically chronic, bilateral, granuloma tous 
keratic precipitates, iris nodules, and anterior and posterior synechia. 
However, non-granulomatous uveitis is two times more common 
than the granulomatous type. Posterior uveitis is observed in 28% 
of cases, usually with extensive venous vascular sheathing (periphle-
bitis) and perivenous infiltrates (candle wax drippings sign), which 
can cause branch retinal venous occlusion and retinal ischemia and 
lead to neovascularization and vitreous hemorrhage. Other ocular 
complications include band keratopathy, glaucoma, and cataracts. 
Intermediate uveitis (6%-10%) and panuveitis (9%-33%) may occur(5). 
There also may be orbital and annexes involvement, mainly in women 
and the elderly. The lacrimal gland is affected in 42% of patients and 
manifests as gland increase and dry-eye symptoms, and orbital invol-
vement presents with proptosis, diplopia, ophthalmoparesis and 
decreased vision(5,6).
Because of its different clinical manifestations, the diagnosis of 
ocular sarcoidosis is difficult and made by exclusion. Chest radiogra-
phy is altered in 90% of cases and is considered the best initial 
exami nation. Classically, ocular sarcoidosis presents with bilateral 
hilar lymphadenopathy but can also demonstrate parenchymal 
opacities or pleural involvement. Chest CT is indicated in cases of 
negative radiography and high suspicion of the disease. Laboratory 
tests, such as angiotensin-converting enzyme, lysozyme, and calcium 
metabolism, may be used but are not specific and are often normal. 
The tuberculin skin test (purified protein derivative skin test) is usually 
anergic. Definitive diagnosis is made by histopathological analyses 
showing non-ca seating epithelioid granuloma in the biopsy of 
affected organs (lung, mediastinal lymph nodes, skin, liver, conjunc-
tiva, salivary, or lacrimal glands). The International Ocular Sarcoidosis 
Workshop graduates the sarcoidosis diagnosis as definitive (biopsy 
result), presumed (typical ocular findings associated with hilar lym-
phadenopathy), probable (ocular signs and compatible laboratory 
tests without hilar adenopathy), and possible (eye and laboratory 
findings compatible but negative biopsy)(3,5,7,8).
Our case is interesting because the patient had clinical features 
consistent with sarcoidosis (young Afro-descendent woman with 
bilateral ocular periphlebitis and lacrimal gland involvement) but also 
had positive serology for toxoplasmosis (IgG and IgM). Since Brazil is 
an endemic country for toxoplasmosis, we decided to start empiri-
cal treatment of this infection, despite the suspicion of sarcoidosis. 
However, the patient did not show improvement in all of her signs, 
so we decided to continue the clinical investigation. The diagnosis 
of presumed ocular sarcoidosis was supported by imaging tests and 
pulmonologist evaluation.
Treatment for ocular sarcoidosis currently involves administra-
tion of systemic corticosteroids. Topical therapy (corticosteroids and 
mydriatics) is administered in addition to systemic corticosteroids in 
cases of anterior uveitis. Intravitreal corticosteroids may also be used in 
posterior uveitis with oral therapy intolerance. Immunosuppressive 
agents can be added to minimize steroid use and control inflamma-
tion, with methotrexate being the preferred choice. Approximately 
10% of cases lead to blindness, especially because of development of 
cystoid macular edema and retinal neovascularization(5,8).
CONCLUSION
Although ocular sarcoidosis is a difficult diagnosis, the disease 
should always be considered in patients with uveitis. Because of its 
wide diversity of clinical signs and symptoms, the disease requires 
careful anamnesis and ophthalmological examination. Ancillary tests, 
such as X-ray radiography, chest and orbital CT, and clinical and labo-
ratory evaluation help in ruling out other causes. Despite the impor-
tance of these ancillary tests, clinical evaluation remains imperative, 
as demonstrated in our case. The treatment consists mainly of oral 
corticosteroids and immunosuppression.
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